Common heart drug may prevent deadly bleeding in liver patients
NCT ID NCT05872698
First seen May 06, 2026 · Last updated May 10, 2026 · Updated 1 time
Summary
This study tests whether beta-blockers, a type of blood pressure medication, can reduce the risk of bleeding from small esophageal varices in people with cirrhosis and portal hypertension. About 763 adults with small varices will receive either beta-blockers or a placebo for up to 3 years. The goal is to see if the drug lowers the chance of serious liver complications like bleeding or liver failure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS, LIVER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
King's College Hospital
London, London, SE5 9RS, United Kingdom
Conditions
Explore the condition pages connected to this study.